Skip to content

Insider · CIK 0001454386

David K. Skeens

cooofficer

Files at NKSH (NATIONAL BANKSHARES INC). First filing -, latest -.

David K. Skeens files SEC Form 4 as COO at NKSH (NATIONAL BANKSHARES INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; David K. Skeens has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Feb 14, 2026NKSH
NATIONAL BANKSHARES INC
AGrant or award
Common Stock
+265$0.00$0327Feb 17, 2026
Feb 11, 2026NKSH
NATIONAL BANKSHARES INC
AGrant or award
Common Stock
+771$0.00$01,098Feb 17, 2026

Questions about David K. Skeens

Answered from the filings on this page, as of the latest one.

Is David K. Skeens buying or selling?

David K. Skeens has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did David K. Skeens's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David K. Skeens has 0.

Where does David K. Skeens file Form 4?

David K. Skeens has filed Form 4 at NKSH (NATIONAL BANKSHARES INC) as EVP/Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.